Skip to main content
. 2021 Mar 9;144(6):1684–1696. doi: 10.1093/brain/awab088

Figure 4.

Figure 4

Comparison of NDI and MWF in normal-appearing brain tissue between patients and controls.Top row: (AD) Compared to healthy subjects (HC), multiple sclerosis (MS) patients show a widespread NODDI-NDI reduction in normal-appearing white matter and—to a smaller extent—a diffuse MWF reduction. Bottom row: There are patchy reductions in MWF and NODDI-NDI in the normal-appearing cortical surface of multiple sclerosis patients versus healthy controls and in PMS versus RRMS patients.